The efficacy of Sepsivac, an immunomodulator used for the treatment of leprosy and manufactured by Ahmedabad-based Cadila Pharmaceuticals, is found to be 70.3% for protection against Covid-19 in healthy persons, according to a recent research study.from Ahmedabad News, Latest Ahmedabad News Headlines & Live Updates - Times of India https://ift.tt/3pW7xBF
No comments:
Post a Comment